Knox Capital

Knox Capital was created to provide capital and hands-on operating resources for founder and entrepreneur-owned middle market businesses under flexible investment horizons through long-term focused private investors. By utilizing our extensive executive and operating advisor network, Knox makes tailored investments across industries in partnership with owners and management.

Mike Bryant

Co-Managing Partner

Alex Gregor

Founder and Partner

Peter Pacelli

Principal

7 past transactions

bundle

Private Equity Round in 2022
Bundle began in 2003 as ANADeeds, providing legal documents to the settlement industry. Attorney-founded and operated, Bundle prides itself on obtaining attorney-prepared documents for some of the nation’s largest Relocation Companies, Settlement Service Providers, Lenders, Title Insurance Companies, and Mortgage Brokers.

Collabtech

Private Equity Round in 2020
Collabtech is a provider of collaboration technology services. Collabtech is a white label services provider, known to help companies collaborate better together. With partners such as Lenovo and HP, the rapidly growing company primarily offers deployment, adoption, maintenance and management support services to help end users maximize their use of Microsoft, Zoom and Google tools.

Authenticity.AI

Seed Round in 2019
Authenticity.ai was founded to provide highly accurate Artificial Intelligence surveillance solutions to the Legal and Compliance industries. they believe custom training is the key for success when using artificial intelligence engines to deliver highly accurate results. The words, faces and objects your organization has is unique, so any AI surveillance solution you use must be trained, just like any new employee who would be joining your company.

a360inc

Private Equity Round in 2019
a360inc is an employee-owned company with a professional board of directors made up of experts representing a cross section of business practices. Watch the video here to learn about our recent history, brand development, and acquisition efforts leading to the a360inc of today.

FluGen

Venture Round in 2016
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.

Phoenix

Debt Financing in 2015
Phoenix designs and manufactures the highest-yielding neutron generators and commercializes nuclear technologies for practical applications. Its commitment to commercializing nuclear technologies for practical applications has inspired its long-term goal of producing clean, fusion energy. Its achievements have enabled Phoenix to market its technologies across a variety of applications within medicine, defense, and energy sectors.

FluGen

Debt Financing in 2014
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.